Pacira, FDA reach agreement on pain drug marketing restrictions

(Reuters) - The U.S. Food and Drug Administration has agreed to drop restrictions on the marketing of Pacira Pharmaceuticals Inc's post-surgery pain drug Exparel, resolving a lawsuit the company filed against the agency earlier this year.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro